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Synthetic Lethality in Pediatric Brain Cancer Cells by Optimized PLGA
Nanoparticles and Drug Combinations
Megan Ruckman, Megan Otte, Dr. Forrest Kievit
Department of Biological Systems Engineering- University of Nebraska Lincoln

Synthetic Lethality and Clonogenic Assay

Nanoparticles and Optimization

On the cellular level, cancer cells are able to divide by repair DNA damage through DNA repair pathways. In order
to survive, cancer cells utilize a certain repair pathway and rely on it to replicate. The idea of synthetic lethality is
that the repair pathway can be inhibited, therefore causing cancer cell death3. The objective of this project is to
sensitize cells, specifically cancer cells, to radiation by utilizing the concept of synthetic lethality.

To accomplish the delivery of DNA repair pathway inhibiting drugs, we use nanoparticles (NPs). This
serves to transport the drugs to cancer cells without damaging healthy tissue so that destroying the tumors
with radiation will be more effective. We used poly(lactic-co-glycolic acid), or PLGA, nanoparticles due to
their safety and simple preparation methods. We must optimize the NPs for size and drug loading to
increase effectiveness. The NPs must be less than 200nm in diameter so they will not be filtered out by the
body, and increasing the drug loading makes them more effective and less expensive. We used
Doxorubicin, an established cancer drug, as a model drug due to its fluorescent properties. Optimization of
the NPs included variation of sonication/stirring, organic and aqueous phases, amount of PLGA, and
amount of Doxorubicin. A single emulsion preparation method was used due to more success in our
previous experiments than a double emulsion. This method uses differences in polarity between the phases
to form layers and force the drug into NPs through sonication (Fig. 4).

Figure 1: a) Hydrogen peroxide and Bleomycin
treatments generate single-strand and double-strand
breaks which mimic the DNA damage caused by
ionizing radiation. b) AZD2461 inhibits the repair of
single-stranded breaks by binding to and inhibiting the
nuclear enzyme, poly(ADP-ribose) polymerase (PARP).
This protein plays a significant role in DNA repair2.

Figure 2: Pictured is a set of
Methylene Blue stained plates
which were utilized to
determine plating efficiency
and the ideal concentration of
cells to be plated for the
clonogenic assay. The well
concentration of U118 cells
per well is labeled in the
image.

The clonogenic assay detects all cells that have the ability to form a
significantly sized colony. This is a standard assay for testing replicative
cell death because it is able to give a precise cell kill measurement. This
assay confirms that DNA damage has occurred and allows for the drug to
be assessed in terms of success of blocking the repair pathway. After
treatment with the drug and the DNA damage agent, the cells are allowed
to grow for 10 days. The growth time allows the replicative ability of the
cells to be measured. The cells are dyed with methylene blue (Fig. 2) and
the colonies over 50 cells are counted.

Results: Drugs
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Figure 3: To mimic the damaging effects of
radiation, cells were subjected to Hydrogen
Peroxide and Bleomycin. DNA damage
methods can be compared in the figures to the
left. On the y-axis is the log of percent
survival, or the cells ability to replicate and
create sizable colonies after DNA damage.
Each graph shows a variety of concentrations
of the chemical that provides DNA damage.
The curves compare one set of cells that was
first treated with 10 uM of the DNA repair
pathway drug AZD 2461.

Results: Nanoparticles
The maximum yield of Doxorubicin achieved in the NPs was
about 10uM. This is significantly higher than in our previous
research, and did not produce nanoparticles that were as large
either. Fig. 5 and Fig. 6 show the effects of two different
conditions that were varied, concentration of poly(vinyl alcohol),
or PVA, and amount of PLGA. Lower concentrations of PVA
produced more favorable NPs (Fig. 5). Fig. 6 shows 50mg of
PLGA producing much less favorable NPs than other amounts,
which does not make sense, so it would be worth running this trial
again to determine if it can produce a balance of high drug loading
and small enough diameter. We believe using more PLGA
produces more drug loading in the NPs, but compromises the size.

Figure 4: An example of an oil in water emulsion
technique similar to what we used our
experiments.
https://www.omicsonline.org/articlesimages/2157-7013-S5-001-g001.gif
Figure 6: PLGA NPs
depicting effects of varying
amounts of PLGA on
diameter and drug loading
under the conditions of
sonication for 3.5min at
75% amplitude, stirring for
1.25hr at 900rpm, w phase
5mL of 2% PVA, and o
phase containing 100µL of
100µM Doxorubicin, 30mg
PLGA, 2.5mL
dichloromethane, and 0.5mL
methanol.

Figure 5: PLGA NPs
demonstrating effects of
varying w phase PVA
concentration on diameter
and drug loading under the
conditions of sonication for
3.5min at 75% amplitude,
stirring for 1.25hr at 900rpm,
and o phase containing
100µL of 100µM
Doxorubicin, 30mg PLGA,
2.5mL dichloromethane, and
0.5mL methanol.

Discussion
The drug AZD2461 works by blocking the cancer’s cells repair pathway. When a single strand break occurs in the DNA, PARP is recruited to repair the DNA break. When AZD2461 is present, PARP is blocked and the DNA cannot be
repaired. The data shows that the blocking of this repair pathway makes the cells easier to kill with radiation. The presence of a drug will ideally make less radiation more effective. The combination of AZD2461 and radiation treatment
caused a decrease in cell survival at low concentrations of hydrogen peroxide and all concentrations of Bleomycin. The next step in this research is to incorporate drug combinations to determine what treatment best sensitizes cells to
radiation treatment. Having produced NPs with significant drug loading, the next step will be to test the Doxorubicin-loaded NPs on glioblastoma cells, as well as incorporate DNA repair pathway inhibiting drugs into NPs.
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